Top Stock Movers Today | Top Stock Gainers & Top Stock Losers

Stock Movers

Gainers

TickerCompany±%Buy Stock
Loading...
Get in real-time

Loser

TickerCompany±%Buy Stock
Loading...
Get in real-time

Stock Movers

Gainers

TickerCompany±%Buy Stock
MTTRMatterport$4.79175.28%2.6MBuy/Sell
AGBAAGBA Group Holding$2.58106.4%4.1MBuy/Sell
MLECMoolec Science$2.3769.28%70.2KBuy/Sell
EDBLEdible Garden AG$6.3167.79%265.3KBuy/Sell
NIVFNewGenIvf Group$1.2967.53%645KBuy/Sell
ZAPPZapp Electric Vehicles$0.2250.13%80.6KBuy/Sell
ATGLAlpha Technology Group$2.8043.18%14.3KBuy/Sell
MNTSMomentus$0.5137.23%1.8MBuy/Sell
GTN/AGray Television$8.1136.21%2.2KBuy/Sell
BTCMBIT Mining$2.7035.67%130.1KBuy/Sell
NKGNNKGen Biotech$1.5035.62%2.9MBuy/Sell
ZCARZoomcar Holdings$0.4135.08%706.9KBuy/Sell
SDIGStronghold Digital Mining$3.6334.94%655.7KBuy/Sell
VIVKVivakor$1.4434.57%137.7KBuy/Sell
PROKProKidney$2.7132.84%660.9KBuy/Sell
ONFOOnfolio Holdings$0.5832.23%24.3KBuy/Sell
MIGIMawson Infra Gr$1.5631.09%564.6KBuy/Sell
LIFWMSP Recovery$1.2430.8%2.4MBuy/Sell
PHIOPhio Pharma$0.8329.67%314.3KBuy/Sell
IONMAssure Hldgs$0.5729.09%1.3MBuy/Sell
Get in real-time

Loser

TickerCompany±%Buy Stock
VAXXVaxxinity$0.27-42.77%447KBuy/Sell
IKTInhibikase Therapeutics$1.38-32.36%135.8KBuy/Sell
BPTHBio-Path Hldgs$2.96-31.01%1.4MBuy/Sell
TWGTop Wealth Group$2.59-30.57%12.4MBuy/Sell
TELOTelomir Pharmaceuticals$5.61-29.75%74.4KBuy/Sell
WRNTWarrantee$0.30-29.42%120.1KBuy/Sell
HEPAHepion Pharmaceuticals$1.43-29.11%76.1KBuy/Sell
WISAWiSA Technologies$4.44-26.74%5.2MBuy/Sell
CDTXCidara Therapeutics$0.51-24.44%693.8KBuy/Sell
SHIMShimmick$2.27-23.06%29KBuy/Sell
YYAIConnexa Sports Techs$0.69-22.73%8.6MBuy/Sell
MRINMarin Software$2.31-21.43%720.5KBuy/Sell
CDXCChromaDex$2.95-20.06%293.7KBuy/Sell
MDIAMediaCo Holding$1.83-19.74%3.9MBuy/Sell
GNLXGenelux$3.33-19.38%132.9KBuy/Sell
ATCHAtlasClear Holdings$1.02-19.17%257.3KBuy/Sell
IZMICZOOM Group$3.20-18.99%780KBuy/Sell
TFFPTFF Pharmaceuticals$2.52-18.98%29.8KBuy/Sell
SLNASelina Hospitality$0.06-18.37%13.5MBuy/Sell
VIAOVIA optronics$0.24-18.28%322.9KBuy/Sell
Get in real-time
Session: Apr 19, 2024 4:00PM EDT - Apr 22, 2024 3:59PM EDT

Stock News of the Day

Best Stock Promotion Right Now

Webull Promotion!
Webull Promotion!
Make a deposit of $100 or more into your account, maintain your funds to get 60 FREE fractional shares! Each share is valued between $3 - $3000!
Disclosure: All investments involve risk, and there is always the possibility that you may lose money when you invest in securities or other financial products. The value of a given security may increase or decrease, and investors may lose money, including their original investment. You should consider your investment objectives carefully before investing. Webull Financial LLC, member FINRA & SIPC. Regulatory and Exchange Fees may apply.

Best Online Stock Brokers

Claim Exclusive Offers

Donald Trump May Soon Receive 36 Million More DJT Shares: Key Milestone Ahead
Truist Financial Reports Mixed Q1 Earnings, Expects Further Decline In Annual Revenues
Tesla Stock Set To Open At Fresh 15-Month Lows: What's Draining EV Maker's Charge?
Truist Financial Reports Mixed Q1 Earnings, Expects Further Decline In Annual Revenues
Tesla Stock Set To Open At Fresh 15-Month Lows: What's Draining EV Maker's Charge?
US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'
Last Week's Worst-Performing Stocks: Are These 11 Large-Cap Stocks In Your Portfolio?

Best Online Stock Brokers

Claim Exclusive Offers

Movers Recent News

Cleveland-Cliffs Q4 Earnings: Revenue Miss, EPS Miss, $1.5B Buyback And More
Cleveland-Cliffs reported first-quarter revenue of $5.2 billion, which missed the consensus estimate of $5.346 billion, according to Benzinga Pro. The company reported adjusted earnings of 18 cents per share, which missed analyst estimates of 22 cents per share.
What's Going On With Agba Stock?
Agba shares are moving on heavy trading volume Monday with more than 183 million shares already traded in the session. According to data from Benzinga Pro, the stock has a float of just over 18 million shares. 
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Legal battle details, implications, and market impact."
Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
Phio Pharmaceuticals unveils findings on PH-762, a promising candidate for cancer therapy. Discover its rapid cell uptake and tumor-inhibiting potential.
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives.
Why MicroStrategy Stock Is Climbing
Bitcoin completed its fourth halving event last Friday and is currently trading up 1.56% over the last 24 hours. Microstrategy CEO Michael Saylor sees the halving as a catalyst for the price of bitcoin due to decreased selling pressure which will allow the price to go up. "You're going to see $12 billion of natural selling per year converted into $6 billion of natural selling per year," Saylor said.
Western Alliance Reports Q1 Earnings, Revenue Beats: What You Need To Know (CORRECTED)
Western Alliance reported quarterly earnings of $1.60 per share, missing the consensus estimate of $1.66 by 3.61% and representing a 30.43% decrease from the same period last year.
What's Going On With Nano-Cap NKGen Biotech Stock On Monday?
Latest on NKGen Biotech Inc (NASDAQ: NKGN) as shares surge 25.2% on high volume. Insights into NK cell therapy for neurodegenerative diseases. Developments in Parkinson's and Alzheimer's treatments.
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
What's Going On With AMC Entertainment Stock?
AMC shares continue their recent rally on Monday in spite of a lack of company specific news. Last Thursday, Wedbush analyst Alicia Reese maintained a Neutral rating on AMC Entertainment and lowered the price target from $6 to $4, citing the company's heavy debt load overshadowing positives including improving box office trends.
Gold Falls Sharply; Matterport Shares Spike Higher
What's Going On With XPeng Stock?
Tesla cut the prices of its Model Y, Model X and Model S vehicles by $2,000 and reduced the price of its Full Self-Driving software from $12,000 to $8,000 in the U.S. Li Auto announced on Monday that it has cut prices by approximately 5% on its L7, Li L8, Li L9, and Li MEGA models and will offer cash refunds to owners who purchased the vehicles earlier in the year.
Bitcoin Miner Hut 8 Is Better Positioned Following The Merger With USBTC, Says Bullish Analyst
Hut 8 shares are in focus as the Bitcoin halving impacts miners. Analysts have a Buy rating with a $12 price target, citing growth potential.
What's Going On With Sify Technologies Stock Monday?
Sify Technologies announced Q4 revenue of INR9.64 billion, missing consensus of $149.30 million. EBITDA improved 11.4% and cash balance was INR5.84 billion.
What's Going On With Luxury EV-Maker Lucid's Stock?
Last week, Lucid revealed new details about the 2024 Lucid Air Grand Touring, including an EPA-estimated range of 516 miles, the longest range of any EV in the U.S. market currently, and a starting price of $109,900.
Why NewGenIvf Stock Is Blasting Higher
The term sheet proposed that NewGen issue 53,600,000 of its ordinary shares to the shareholder(s) of EWIHL in exchange for 100% equity interest of EWIHL, at a price per share of $5, representing an aggregate amount of $268 million. Simultaneously, it is proposed that NewGen raise $30 million from public or private shareholders, in a form mutually acceptable to both NewGen and EWIHL.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers